• 대한약침학회지
• /
• 제15권2호
• /
• pp.31-35
• /
• 2012

Background and Objectives: Non-small-cell lung cancer (NSCLC) represents approximately 80% of all lung cancers. Unfortunately, at their time of diagnosis, most patients have advanced to unresectable disease with a very poor prognosis. The oriental herbal medicine HangAm-Plus (HAP) has been developed for antitumor purposes, and several previous studies have reported its therapeutic effects. In this study, the efficacy of HAP was evaluated as a third-line treatment for advanced-stage IIIb/IV NSCLC. Methods: The study involved six patients treated at the East- West Cancer Center (EWCC) from April 2010 to October 2011. Inoperable advanced-stage IIIb/IV NSCLC patients received 3,000 or 6,000 mg of HAP on a daily basis over a 12-week period. Computed tomography (CT) scans were obtained from the patients at the time of the initial administration and after 12 weeks of treatment. We observed and analyzed the patients overall survival (OS) and progression-free survival (PFS). Results: Of the six patients, three expired during the study, and the three remaining patients were alive as of October 31, 2011. The OS ranged from 234 to 512 days, with a median survival of 397 days and a one-year survival rate of 66.7%. In the 12-week-interval chest CT assessment, three patients showed stable disease (SD), and the other three showed progressive disease (PD). The PFS of patients ranged from 88 to 512 days, the median PFS being 96 days. Longer OS and PFS were correlated with SD. Although not directly comparable, the OS and the PFS of this study were greater than those of the docetaxel or the best supportive care group in other studies. Conclusion: HAP may prolong the OS and the PFS of inoperable stage IIIb/IV NSCLC patients without significant adverse effects. In the future, more controlled clinical trials with larger samples from multi-centers should be conducted to evaluate the efficacy and the safety of HAP.

• Korean Journal of Radiology
• /
• 제21권6호
• /
• pp.764-772
• /
• 2020

Objective: Laser ablation is a therapeutic modality used to reduce the volume of large benign thyroid nodules. Unsatisfactory reduction and regrowth are observed in some treated nodules. The aim of the study was to evaluate the long-term outcomes of laser treatment for solid nodules during a 5-year follow-up period, the regrowth rate, and the predictive risk factors of nodule regrowth. Materials and Methods: We retrospectively evaluated patients with benign, solid, cold thyroid nodules who underwent laser ablation and were followed-up for 5 years. According to the selection criteria, 104 patients were included (median baseline nodule volume, 12.5 mL [25.0-75.0%, 8-18 mL]; median energy delivered, 481.5 J/mL [25.0-75.0%, 370-620 J/mL]). Nodule volume, thyroid function test results, and ultrasound were evaluated at baseline and then annually after the procedure. Results: Of 104 patients, 31 patients (29.8%) had a 12-month volume reduction ratio (VRR) < 50.0% and 39 (37.5%) experienced nodule regrowth. Of these 39 patients, 17 (43.6%) underwent surgery and 14 (35.9%) underwent a second laser treatment. The rate of nodule regrowth was inversely related to the 12-month VRR, i.e., the lower the 12-month VRR, the higher the risk of regrowth (p < 0.001). The mean time for nodule regrowth was 33.5 ± 16.6 months. The 12-month VRR was directly related to time to regrowth, i.e., the lower the 12-month VRR, the shorter the time to regrowth (p < 0.001; R² = 0.3516). Non-spongiform composition increased the risk of regrowth with an odds ratio of 4.3 (95% confidence interval [CI] 1.8-10.2; p < 0.001); 12-month VRR < 50.0% increased the risk of regrowth with an odds ratio of 11.7 (95% CI 4.2-32.2; p < 0.001). Conclusion: The VRR of thyroid nodules subjected to similar amounts of laser energy varies widely and depends on the nodule composition; non-spongiform nodules are reduced to a lesser extent and regrow more frequently than spongiform nodules. A 12-month VRR < 50.0% is a predictive risk factor for regrowth and correlates with the time to regrowth.

• Journal of Web Engineering
• /
• 제14권19호
• /
• pp.4103-4118
• /
• 2022

The physiological or dietary advantages of germinated grains have been the subject of numerous discussions over the past decade. Around 23 million tons of oats are consumed globally, making up a sizeable portion of the global grain market. Oat seedlings contain more protein, beta-glucan, free amino acids, and phenolic compounds than seeds. The progressive neurodegenerative disorder of Alzheimer's is accompanied by worsening memory and cognitive function. A key indicator of this disorder is the unusual buildup of amyloid-beta protein (or Aβ) in human brains. In this context, oat seedling extract (OSE) has been identified as a new therapeutic candidate for AD, due to its antioxidant activity and AD-specific mechanism of action. This study directly investigated how OSE affected AD and its impacts by examining the cognitive function and exploring the inflammatory response mechanism. The dried oat seedlings were grounded finely with a grinder, inserted with 50% fermented ethanol 10 times (w/v), and extracted by stirring for 10 h at 45 ℃. After filtering the extract by 0.22 um filter, some of it was used for UHPLC analysis. The results indicated that the treatment with OSE protects against Aβ25-35-induced cytotoxicity in BV2 cells. Tg-5Xfad AD mice had strong deposition of Aβ throughout their brains, while WT mice did not exhibit any such deposition within their brains. A drastic reduction was observed in terms of numbers, as well as the size, of Aβ plaques within Tg-5Xfad AD mice exposed to OSE. This study indicated OSE's neuroprotective impacts against neurodegeneration, synaptic dysfunction, and neuroinflammation induced by amyloid-beta. Our results suggest that OSE acts as a neuroprotective agent to combat AD-specific apoptotic cell death, neuroinflammation, amyloid-beta accumulation, as well as synaptic dysfunction in AD mice's brains. Furthermore, the study indicated that OSE treatment affects JNK/ERK/p38 MAPK signaling, with considerable inhibition in p-JNK, p-p38, and p-ERK levels seen in the brain of OSE-treated Tg-5Xfad AD mice.

• 대한방사선치료학회지
• /
• 제29권2호
• /
• pp.27-32
• /
• 2017

목 적: 고주파 온열암 치료에 의한 부작용 중에서 가장 주의하여할 것 중의 하나는 피부에 나타날 수 있는 화상이다. 특히 배꼽처럼 요철이 있는 부위에는 환자가 느끼는 열감이 크기 때문에 치료를 중단하는 경우가 발생한다. 이에 배꼽부위의 요철을 상쇄시키기 위한 보상체를 제작하고 온도 및 열감을 감소시키고자 한다. 대상 및 방법: 고주파 온열암 치료기(EHY-2000, Oncotherm Kft, Hungary)를 이용하여 본원에서 치료받은 환자를 대상으로 배꼽을 중심으로 4개 부위(배꼽 속, 배꼽 바로 옆, 배꼽아래 5 cm 지점, 등)의 온도를 5회에 걸쳐 측정하였다. 온도계(TM-100, Oncotherm Kft, Hungary)를 4개의 부위에 부착하고 치료 전, 치료 후 5분, 15분, 25분, 35분, 50분의 온도를 측정하였다. 이때 사용한 보상체는 바셀린, 볼루스, 레진으로 각각 같은 방법으로 측정하였다. 결 과: 일반적 치료 시 배꼽 속 온도변화는 평균 34.65도에서 42.9도로 변화하였다. 배꼽 바로 옆은 32.20도에서 37.00도까지 변화하였으며 배꼽아래는 31.90도에서 34.41도로 변화하여 배꼽속의 온도변화가 가장 큰 것으로 나타났다. 배꼽 속에 보상체 물질을 삽입한 경우의 배꼽 속 온도변화는 볼루스가 5.42도, 바세린이 6.55도, 레진이 6.83도로 측정되었다. 온도상승 검증을 위한 귀무가설의 유의확률은 각각 0.0108, 0.034, 0.019로 기각되었다. 결 론: 고주파 온열암 치료 시 환자가 느끼는 열감은 치료의 중단을 가져올 수도 있는 중요한 인자로서 배꼽과 같은 요철부위에 보상체를 사용 시 열감을 줄일 수 있었다. 보상체는 개인마다 요철의 모양이 다르기 때문에 맞춤제작이 가능한 레진이 유리하며, 온도를 낮출 뿐 아니라 환자가 느끼는 열감 또한 상당히 감소하는 것으로 나타났다. 추후 열전달 모델의 개발이 가능하다면 치료 시 나타나는 열감을 줄이며 보다 정확하고 편안한 치료를 제공 할 수 있을 것으로 사료된다.

• 대한미생물학회지
• /
• 제21권3호
• /
• pp.311-329
• /
• 1986

The experimental exposure of animals to sources of ultraviolet radiation (UVR) which emit their energy primarily in the UVB region (280-320nm) is known to result in a number of well-described changes in the recipient's immune competence. Two such changes include a depressed capacity to effectively respond immunologically to transplants of syngeneic UVR tumors and a markedly reduced responsiveness to known inducers of delayedtype (DTH) and contact hypersensitivity (CH) reactions. The results of experiments that were designed to elucidate the mechanisms responsible for UVR-induced immunomodulation have implicated: 1) an altered pattern of lymphocyte recirculation, 2) suppressor T cells(Ts), 3) deviations in systemic antigen presenting cell (APC) potential. 4) changes in the production of interleukin-1-like molecules, and 5) the functional inactivation of epidermal Langerhans cells in this process. The exposure of skin to UVR, therefore, causes a number of both local and systemic alterations to the normal host immune system. In spite of this seeming complexity and diversity of responses, our recent studies have established that each of the UVR-mediated changes is probably of equal importance to creating the UVR-induced immunocompromised state. Normal animals were exposed to low dose UVR radiation on their dorsal surfaces under conditions where a $3.0\;cm^2$ area of skin was physically protected from the light energy. Contact sensitization of these animals with DNFB, to either the irradiated or protected back skin, resulted in markedly reduced CH responses. This was observed in spite of a normal responsiveness following the skin sensitization to ventral surfaces of the UVR-exposed animals. Systemic treatment of the low dose UVR recipients with the drug indomethacin (1-3 micrograms/day) during the UVR exposures resulted in a complete reversal of the depressions observed following DNFB sensitization to "protected" dorsal skin while the altered responsiveness found in the group exposed to the skin reactive chemical through directly UVR-exposed sites was maintained. These studies implicate the importance of EC as effective APC in the skin and also suggest that some of the systemic influences caused by UVR exposure involve the production of prostaglandins. This concept was further supported by finding that indomethacin treatment was also capable of totally reversing the systemic depressions in CH responsiveness caused by high dose UVR exposure (30K joules/$m^2$) of mice. Attempts to analyze the cellular mechanisms responsible established that the spleens of all animals which demonstrated altered CH responses, regardless of whether sensitization was through a normal or an irradiated skin site, contained suppressor cells. Interestingly, we also found normal levels of T effector cells in the peripheral lymph nodes of the UVR-exposed mice that were contact sensitized through normal skin. No effector cells were found when skin sensitization took place through irradiated skin sites. In spite of such an apparent paradox, insight into the probable mechanisms responsible for these observations was provided by establishing that UVR exposure of skin results in a striking and dose-dependent blockade of the efferent lymphatic vessels in all peripheral lymph nodes. Therefore, the afferent phases of immune responses can apparently take place normally in UVR exposed animals when antigen is applied to normal skin. The final effector responses, however, appear to be inhibited in the UVR-exposed animals by an apparent block of effector cell mobility. This contrasts with findings in the normal animals. Following contact sensitization, normal animals were also found to simultaneously contain both antigen specific suppressor T cells and lymph node effector cells. However, these normal animals were fully capable of mobilizing their effector cells into the systemic circulation, thereby allowing a localization of these cells to peripheral sites of antigen challenge. Our results suggest that UVR is probably not a significant inducer of suppressor T-cell activity to topically applied antigens. Rather, UVR exposure appears to modify the normal relationship which exists between effector and regulatory immune responses in vivo. It does so by either causing a direct reduction in the skin's APC function, a situation which results in an absence of effector cell generation to antigens applied to UVR-exposed skin sites, inhibiting the capacity of effector cells to gain access to skin sites of antigen challenge or by sequestering the lymphocytes with effector cell potential into the draining peripheral lymph nodes. Each of these situations result in a similar effect on the UVR-exposed host, that being a reduced capacity to elicit a CH response. We hypothesize that altered DTH responses, altered alloresponses, and altered graft-versus-host responses, all of which have been observed in UVR exposed animals, may result from similar mechanisms.

• 한국토양비료학회지
• /
• 제44권5호
• /
• pp.808-813
• /
• 2011

벼 재배시 농가에서 화학비료 사용량을 절감하기 위해 토양검정에 의한 양분관리 방법을 수립하고자 하였다. 그 결과 처리간에 수확기 토양의 EC, 유효규산, 치환성 Ca은 감소하였고, pH, 유기물함량, 치환성 K와 Mg은 변화가 없었다. 수확기 토양미생물은 시비전에 비해 호기성균, Bacilus sp. 사상균은 증가하였고, 퇴비 50%를 사용한 처리에서 호기성세균이 다량분포하고 있었다. 표준시비구와 퇴비를 50% 사용하였을 경우에는 잎의 N, P, K 함량은 비슷하였다. 벼 생육상황과 엽록소함량은 무비구를 제외한 모든 처리구에서 비슷한 수준을 보였다. 수량은 검정시비량 50%+퇴비 50% 처리구가 가장 많았고, 무비구에서 가장 적었으며, 처리별로 비교해보면 검정시비량 50%+퇴비 50%구> 표준시비구>검정시비량70%+퇴비 30%구>검정시비구>무비구 순이었다. 쌀의 아밀로오스 함량은 17.2~17.8%로서 비슷하였고, 단백질 함량은 5.9%~6.8%로 화학비료 사용량이 적을수록 낮았고, 기계적인 식 미치는 높게 나타났다. 따라서 친환경 쌀 생산을 위하여 화학비료 표준시비량을 검정시비량 50%에 퇴비 50%를 사용하는 것이 기준수확량을 유지함과 동시에 식미 향상효과가 있어 축분퇴비의 시비기술 측면에서 개선 또는 재검토 되어야 한다.

• 생물환경조절학회지
• /
• 제28권2호
• /
• pp.178-184
• /
• 2019

딸기는 세계적으로 중요하고 인기있는 과채류이며 '설향'은 국내 시장에서 재배되고 있는 주요 품종 중 하나이다. 딸기의 생장과 화아 유도는 이 작물의 과실에 수량에 직접적으로 영향을 미치는 과정이다. 본 연구에서는 벤질아데닌(BA), 지베렐린 산($GA_3$), 살리실 산(SA)이 '설향' 딸기의 생장과 화아 유도에 미치는 영향을 조사하였다. 21구 트레이에서 번식된 지 3주가 경과한 런너묘를 온도는 $25^{\circ}C/15^{\circ}C$(주간/야간), 상대습도는 70%, 광원은 백색 LED, 광도는 $300{\mu}mol{\cdot}m^{-2}{\cdot}s^{-1}\;PPFD$로 유지되는 생장 챔버에서 재배하였다. BA, $GA_3$ 및 SA를 각 0(대조구), 100, $200mg{\cdot}L^{-1}$로 런너묘에 처리하였다. 이러한 생장조절제를 런너묘의 잎에 2주 간격으로 2회 엽면살포하였다. 9주 후의 생육을 비교한 결과, 생장조절제를 엽면살포한 모든 처리에서 대조구에 비해 근장과 엽록소함량(SPAD)이 감소하는 경향을 보였다. $GA_3$ 처리에서 엽록소함량(SPAD)이 가장 낮았다. 하지만 $GA_3\;200mg{\cdot}L^{-1}$ 처리에서 엽면적, 잎 생체중, 식물 생체중이 증가하였다. 화아유도율과 화수는 $SA\;200mg{\cdot}L^{-1}$ 처리에서 각 85%와 식물체당 4.3개로 가장 높았고 그 다음으로 $SA\;200mg{\cdot}L^{-1}$ 처리에서 높았다. 전체적으로 $GA_3$ 처리에서 식물 생장을 향상시켰고, SA 처리에서는 개화를 촉진하였다. 더 나아가 $GA_3$와 SA를 혼합한 처리를 추가한 연구를 수행하여 생장조절제간의 관계를 구명하고 그 결과에서의 분자 메커니즘과 관련된 반응을 조사하는 것이 필요하다고 판단된다.

• 구강회복응용과학지
• /
• 제35권3호
• /
• pp.160-169
• /
• 2019

목적: 이번 연구의 목적은 정적인 방법과 동적인 방법으로 형성된 지르코니아 표면에 부착된 바이오필름에 대한 LED 칫솔의 항균 효과를 평가하고자 하였다. 연구 재료 및 방법: 구강 바이오필름을 형성하기 위해 직경 12 mm, 두께 2.5 mm의 지르코니아 디스크를 24-well plate(정적 방법)와 Center for Disease Control and Prevention (CDC) biofilm reactor (동적 방법)에 디스크를 넣어 바이오필름을 형성하였다. 디스크는 아무 처치도 하지 않은 대조군, 상용화된 광역학(PDT) 키트, 치솔질(brushing) 단독, LED 치솔군, LED 치솔과 에리스로신을 같이 적용한 군, 이렇게 5개 그룹으로 구성하였다. 각 군별 처치 후, 개별 디스크를 시험관에 넣고 60 초 동안 vortexing하여 세균을 분리한 후, 분리된 세균 용액을 선택 배지를 이용하여 살아있는 세균 수를 확인한 후 실험 방법에 따른 항균 효과를 계측하였고, 주사전자현미경(SEM)을 통하여 세균의 형태 변화를 관찰하였다. 결과: 바이오필름의 형성과 구성비는 동적인 방법과 정적인 방법에 따른 차이는 관찰되지 않았다. 대조군과 실험군간에 세균의 생존률에 유의한 차이가 있었다(P < 0.05). LED 치솔과 에리스로신을 같이 적용한 군에서 가장 높은 항균 효과가 관찰되었다(P < 0.05). 주사전자현미경 사진상에서 광역학치료군과, LED 치솔군, LED 치솔과 에리스로신을 같이 적용한 군은 세균의 형태 변화가 관찰되었으나, 대조군과 치솔질 단독 사용군에서는 세균의 형태 변화가 관찰되지 않았다. 결론: 이번 연구 결과 지르코니아 표면에 부착된 바이오필름을 효과적으로 제거하는 방법으로 LED 치솔과 에리스로신을 같이 적용하는 것이 추천된다.

• Biomolecules & Therapeutics
• /
• 제23권3호
• /
• pp.218-224
• /
• 2015

Endocannabinoids can affect multiple cellular targets, such as cannabinoid (CB) receptors, transient receptor potential cation channel, subfamily V, member 1 (TRPV1) and peroxisome proliferator-activated receptor ${\gamma}$($PPAR{\gamma}$). The stimuli to induce adipocyte differentiation in hBM-MSCs increase the gene transcription of the $CB_1$ receptor, TRPV1 and $PPAR{\gamma}$. In this study, the effects of three endocannabinoids, N-arachidonoyl ethanolamine (AEA), N-arachidonoyl dopamine (NADA) and 2-arachidonoyl glycerol (2-AG), on adipogenesis in hBM-MSCs were evaluated. The adipocyte differentiation was promoted by AEA whereas inhibited by NADA. No change was observed by the treatment of non-cytotoxic concentrations of 2-AG. The difference between AEA and NADA in the regulation of adipogenesis is associated with their effects on $PPAR{\gamma}$ transactivation. AEA can directly activate $PPAR{\gamma}$. The effect of AEA on $PPAR{\gamma}$ in hBM-MSCs may prevail over that on the $CB_1$ receptor mediated signal transduction, giving rise to the AEA-induced promotion of adipogenesis. In contrast, NADA had no effect on the $PPAR{\gamma}$ activity in the $PPAR{\gamma}$ transactivation assay. The inhibitory effect of NADA on adipogenesis in hBM-MSCs was reversed not by capsazepine, a TRPV1 antagonist, but by rimonabant, a $CB_1$ antagonist/inverse agonist. Rimonabant by itself promoted adipogenesis in hBM-MSCs, which may be interpreted as the result of the inverse agonism of the $CB_1$ receptor. This result suggests that the constantly active $CB_1$ receptor may contribute to suppress the adipocyte differentiation of hBM-MSCs. Therefore, the selective $CB_1$ agonists that are unable to affect cellular $PPAR{\gamma}$ activity inhibit adipogenesis in hBM-MSCs.

• 한국산학기술학회논문지
• /
• 제15권7호
• /
• pp.4665-4674
• /
• 2014

본 연구에서는 분리막을 이용하여 혐기성소화액을 분리막으로 고/액 분리할 때 발생하는 막오염을 방지하기 위하여 전기응집을 전처리 공정으로 적용 가능한지 여부를 평가하였다. 전기응집 공정의 전극면적, 전류밀도 및 접촉시간에 따른 막오염 저감 효과를 분석하였다. 전극 침지 면적이 작은 경우 전계의 세기가 높아져 미생물 플록 및 셀의 파괴 현상으로 인한 용존 COD의 증가 현상이 관찰되었으나, 전극 침지 면적이 큰 경우에 용존 COD는 큰 변화를 보이지 않았다. 그러나 T-P는 전극에서 용출된 알루미늄 이온과 침전하여 전기응집 후 크게 감소하였다. 전류밀도가 증가함에 따라 막 투과 플럭스가 증가하여 결과적으로 막오염 저항값 (Rc+Rf)은 감소하였다. 혐기성 소화액의 입자 크기는 전기응집 후에 약간 증가하였으나 입자크기 증가가 막오염 저감의 직접적인 원인은 아닌 것으로 나타났다. 전기응집으로 발생한 $AlPO_4$와 같은 무기성 부유 물질이 분리막 표면에서 dynamic membrane으로 작용하여 막오염을 저감시킨 것으로 나타났다.